181 related articles for article (PubMed ID: 36082628)
1. Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.
Lorenzo-Herrero S; Sordo-Bahamonde C; Martínez-Pérez A; Corte-Torres MD; Fernández-Vega I; Solís-Hernández MP; González S
Cancer Sci; 2023 Jan; 114(1):48-62. PubMed ID: 36082628
[TBL] [Abstract][Full Text] [Related]
2. BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression.
Mandel I; Haves Ziv D; Goldshtein I; Peretz T; Alishekevitz D; Fridman Dror A; Hakim M; Hashmueli S; Friedman I; Sapir Y; Greco R; Qu H; Nestle F; Wiederschain D; Pao L; Sharma S; Ben Moshe T
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096532
[TBL] [Abstract][Full Text] [Related]
3. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
[TBL] [Abstract][Full Text] [Related]
5. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
6. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia.
Villa-Álvarez M; Sordo-Bahamonde C; Lorenzo-Herrero S; Gonzalez-Rodriguez AP; Payer AR; Gonzalez-Garcia E; Villa-Álvarez MC; López-Soto A; Gonzalez S
Front Immunol; 2018; 9():2917. PubMed ID: 30619281
[TBL] [Abstract][Full Text] [Related]
7. CD8
Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
[TBL] [Abstract][Full Text] [Related]
8. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
9. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
10. Increased ILT2 expression contributes to dysfunction of CD56
Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
[TBL] [Abstract][Full Text] [Related]
12. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating and peripheral CD4
Jacquier A; Lambert T; Delattre JF; Djouadou M; Vérine J; Dumont C; Desgrandchamps F; Carosella ED; LeMaoult J; Rouas-Freiss N
Cancer Lett; 2021 Oct; 519():105-116. PubMed ID: 34186161
[TBL] [Abstract][Full Text] [Related]
14. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
Favier B; Lemaoult J; Lesport E; Carosella ED
FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
[TBL] [Abstract][Full Text] [Related]
15. HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.
Sun YX; Feng Q; Wang SW; Li X; Sheng Z; Peng J
Ann Hematol; 2022 Apr; 101(4):739-748. PubMed ID: 35041051
[TBL] [Abstract][Full Text] [Related]
16. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model.
Reardon DA; Gokhale PC; Klein SR; Ligon KL; Rodig SJ; Ramkissoon SH; Jones KL; Conway AS; Liao X; Zhou J; Wen PY; Van Den Abbeele AD; Hodi FS; Qin L; Kohl NE; Sharpe AH; Dranoff G; Freeman GJ
Cancer Immunol Res; 2016 Feb; 4(2):124-35. PubMed ID: 26546453
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
Front Immunol; 2020; 11():608614. PubMed ID: 33505397
[TBL] [Abstract][Full Text] [Related]
19. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
20. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]